Executive Committee

Chair

Charles Wilson

President and Chief Executive Officer of Unum Therapeutics

Counsel

Larry Wittenberg

Senior Partner, Technology Companies & Life Sciences Group at Goodwin

Immediate Past Chair

David Lucchino

Co-founder, President and Chief Executive Officer of Frequency Therapeutics

Directors

Chip Clark

President and Chief Executive Officer, Genocea Biosciences, Inc.

Sharon Cload

Vice President, Discovery Biotherapeutics, Bristol Myers Squibb

John Dunlop

Vice President, Neuroscience Research at Amgen

Sue Hager

Chief Communications Officer, SVP Corporate Affairs & Citizenship, EQRx

Lizabeth Leveille

Associate Vice President and Head, Boston Innovation Hub of BD&L Merck Research Laboratories

Liz Lewis

Chief Counsel, Specialty BUs/R&D and the Head of Patient Advocacy at Takeda Oncology

Eric Rasmussen

Vice President, Government Relations and Public Affairs at Sunovion

Bill Sibold

Executive Vice President and Head of Sanofi Genzyme

Kumar Srinivasan

Vice-President, Scientific Partnering and Alliances and Site Head, R&D Boston at AstraZeneca

Tamar Thompson

Vice President, U.S. Government Affairs, Alexion Pharmaceuticals, Inc.

Rehan Verjee

President, EMD Serono, Global Head of the Innovative Medicine Franchises, Member of the Healthcare Executive Committee, Merck KGaA, Darmstadt, Germany